Use of CA-125 and ultrasound in high-risk women
- 1 January 2002
- journal article
- Published by BMJ in International Journal of Gynecologic Cancer
- Vol. 12 (1), 86-91
- https://doi.org/10.1046/j.1525-1438.2002.01055.x
Abstract
Laframboise S, Nedelcu R, Murphy J, Cole DEC, Rosen B. Use of CA‐125 and ultrasound in high‐risk women. Our objective was a retrospective study reporting on ovarian cancer screening in a high‐risk female population using both CA‐125 and ultrasound over a 7‐year period. We used risk estimates of carrying a BRCA mutation that were based on family history. Subjects were screened with CA‐125 and ultrasound every 6 months. Each of 311 high‐risk subjects had between 1 and 17 screening visits. Overall, 33 of 1209 (2.7%) CA‐125 results were abnormal (>35 U/ml); 226 of 1342 (17%) ultrasounds were abnormal, with abnormalities ranging from benign appearing cystic changes to more ominous patterns. Since entry into the program, 29 subjects (9%) have undergone surgery. In 20 of these, the preoperative screening was normal; in six, only the ultrasound was abnormal, and in two, only the CA‐125 was abnormal (46–91 U/ml). In only one subject undergoing surgery were both serial CA‐125 levels (52–91 U/ml) and ultrasound abnormal. In 7 years of screening, one patient (0.3%) has been diagnosed with ovarian cancer (stage IA, grade 1 endometrioid adenocarcinoma). Overall, 31 (10%) subjects have completed BRCA testing. We conclude that despite screening results comparable to other studies, the detection of only one ovarian cancer over 7 years is lower than expected. Explanations for this observation are discussed. Despite the limitations of CA‐125 and ultrasound, we continue to recommend these screening modalities for high‐risk women. At the present time, they offer the best opportunity to detect ovarian cancers early. With increasing knowledge of BRCA testing, more women may benefit from this testing in assessing their personal risk.Keywords
This publication has 22 references indexed in Scilit:
- Prevalence and Penetrance of Germline BRCA1 and BRCA2 Mutations in a Population Series of 649 Women with Ovarian CancerAmerican Journal of Human Genetics, 2001
- Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevationBritish Journal of Cancer, 1999
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesAmerican Journal of Human Genetics, 1998
- Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort studyBMJ, 1996
- Rapid detection of BRCA1 mutations by the protein truncation testNature Genetics, 1995
- Ovarian CancerJama-Journal Of The American Medical Association, 1995
- Screening for Ovarian Cancer: The Preliminary Experience of a Familial Ovarian Cancer CenterGynecologic Oncology, 1993
- Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography.BMJ, 1993
- Ultrasound screening for familial ovarian cancerGynecologic Oncology, 1991
- Detection of Malignant Ovarian NeoplasmsObstetrical & Gynecological Survey, 1984